Literature DB >> 32142354

PKCδ causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction.

Leroy C Joseph1, Michael V Reyes1, Kundanika R Lakkadi1, Blake H Gowen1, Gyorgy Hasko2, Konstantinos Drosatos3, John P Morrow1.   

Abstract

Sepsis-induced cardiomyopathy (SIC) is associated with increased patient mortality. At present, there are no specific therapies for SIC. Previous studies have reported increased reactive oxygen species (ROS) and mitochondrial dysfunction during SIC. However, a unifying mechanism remains to be defined. We hypothesized that PKCδ is required for abnormal calcium handling and cardiac mitochondrial dysfunction during sepsis and that genetic deletion of PKCδ would be protective. Polymicrobial sepsis induced by cecal ligation and puncture (CLP) surgery decreased the ejection fraction of wild-type (WT) mice but not PKCδ knockout (KO) mice. Similarly, WT cardiomyocytes exposed to lipopolysaccharide (LPS) demonstrated decreases in contractility and calcium transient amplitude that were not observed in PKCδ KO cardiomyocytes. LPS treatment decreased sarcoplasmic reticulum calcium stores in WT cardiomyocytes, which correlated with increased ryanodine receptor-2 oxidation in WT hearts but not PKCδ KO hearts after sepsis. LPS exposure increased mitochondrial ROS and decreased mitochondrial inner membrane potential in WT cardiomyocytes. This corresponded to morphologic changes consistent with mitochondrial dysfunction such as decreased overall size and cristae disorganization. Increased cellular ROS and changes in mitochondrial morphology were not observed in PKCδ KO cardiomyocytes. These data show that PKCδ is required in the pathophysiology of SIC by generating ROS and promoting mitochondrial dysfunction. Thus, PKCδ is a potential target for cardiac protection during sepsis.NEW & NOTEWORTHY Sepsis is often complicated by cardiac dysfunction, which is associated with a high mortality rate. Our work shows that the protein PKCδ is required for decreased cardiac contractility during sepsis. Mice with deletion of PKCδ are protected from cardiac dysfunction after sepsis. PKCδ causes mitochondrial dysfunction in cardiac myocytes, and reducing mitochondrial oxidative stress improves contractility in wild-type cardiomyocytes. Thus, PKCδ is a potential target for cardiac protection during sepsis.

Entities:  

Keywords:  PKCδ; mitochondria; reactive oxygen species; sepsis

Mesh:

Substances:

Year:  2020        PMID: 32142354      PMCID: PMC7191496          DOI: 10.1152/ajpheart.00749.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

Review 1.  PKC-delta and PKC-epsilon: foes of the same family or strangers?

Authors:  Nicolas Duquesnes; Frank Lezoualc'h; Bertrand Crozatier
Journal:  J Mol Cell Cardiol       Date:  2011-07-23       Impact factor: 5.000

2.  An integrated clinico-metabolomic model improves prediction of death in sepsis.

Authors:  Raymond J Langley; Ephraim L Tsalik; Jennifer C van Velkinburgh; Seth W Glickman; Brandon J Rice; Chunping Wang; Bo Chen; Lawrence Carin; Arturo Suarez; Robert P Mohney; Debra H Freeman; Mu Wang; Jinsam You; Jacob Wulff; J Will Thompson; M Arthur Moseley; Stephanie Reisinger; Brian T Edmonds; Brian Grinnell; David R Nelson; Darrell L Dinwiddie; Neil A Miller; Carol J Saunders; Sarah S Soden; Angela J Rogers; Lee Gazourian; Laura E Fredenburgh; Anthony F Massaro; Rebecca M Baron; Augustine M K Choi; G Ralph Corey; Geoffrey S Ginsburg; Charles B Cairns; Ronny M Otero; Vance G Fowler; Emanuel P Rivers; Christopher W Woods; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

3.  Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical Setting.

Authors:  Giora Landesberg; Phillip D Levin; Dan Gilon; Sergey Goodman; Milena Georgieva; Charles Weissman; Allan S Jaffe; Charles L Sprung; Vivian Barak
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

4.  Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.

Authors:  Ce Xu; Chenju Yi; Huiping Wang; Iain C Bruce; Qiang Xia
Journal:  Shock       Date:  2012-01       Impact factor: 3.454

Review 5.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 6.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

7.  Mechanisms of cardiac and renal dysfunction in patients dying of sepsis.

Authors:  Osamu Takasu; Joseph P Gaut; Eizo Watanabe; Kathleen To; R Eliot Fagley; Brian Sato; Steve Jarman; Igor R Efimov; Deborah L Janks; Anil Srivastava; Sam B Bhayani; Anne Drewry; Paul E Swanson; Richard S Hotchkiss
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

Review 8.  Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.

Authors:  Steven O Marx; Andrew R Marks
Journal:  J Mol Cell Cardiol       Date:  2013-03-16       Impact factor: 5.000

9.  SERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesis.

Authors:  Ion A Hobai; Emmanuel S Buys; Justin C Morse; Jessica Edgecomb; Eric H Weiss; Antonis A Armoundas; Xiuyun Hou; Alok R Khandelwal; Deborah A Siwik; Peter Brouckaert; Richard A Cohen; Wilson S Colucci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-09       Impact factor: 4.733

10.  Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy.

Authors:  Dimitra Kokkinaki; Matthew Hoffman; Charikleia Kalliora; Ioannis D Kyriazis; Jennifer Maning; Anna Maria Lucchese; Santhanam Shanmughapriya; Dhanendra Tomar; Joon Young Park; Hong Wang; Xiao-Feng Yang; Muniswamy Madesh; Anastasios Lymperopoulos; Walter J Koch; Melpo Christofidou-Solomidou; Konstantinos Drosatos
Journal:  J Mol Cell Cardiol       Date:  2019-01-03       Impact factor: 5.000

View more
  6 in total

1.  Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.

Authors:  Deanna K Sosnowski; K Lockhart Jamieson; Artiom Gruzdev; Yingxi Li; Robert Valencia; Ala Yousef; Zamaneh Kassiri; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

Review 2.  Mitochondrial Homeostasis Mediates Lipotoxicity in the Failing Myocardium.

Authors:  Tom Kretzschmar; Jasmine M F Wu; P Christian Schulze
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

3.  CircTLK1 modulates sepsis-induced cardiomyocyte apoptosis via enhancing PARP1/HMGB1 axis-mediated mitochondrial DNA damage by sponging miR-17-5p.

Authors:  Yu Qiu; Ying Yu; Xiao-Mei Qin; Tao Jiang; Yan-Fang Tan; Wen-Xian Ouyang; Zheng-Hui Xiao; Shuang-Jie Li
Journal:  J Cell Mol Med       Date:  2021-08-19       Impact factor: 5.310

4.  Lipopolysaccharide Modifies Sodium Current Kinetics through ROS and PKC Signalling in Induced Pluripotent Stem-Derived Cardiomyocytes from Brugada Syndrome Patient.

Authors:  Zhenxing Liao; Yingrui Li; Xuehui Fan; Zhen Yang; Ibrahim El-Battrawy; Xiaobo Zhou; Ibrahim Akin
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-15

Review 5.  Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction.

Authors:  Qingzeng Gao; Marina Sorrentino Hernandes
Journal:  Inflammation       Date:  2021-07-21       Impact factor: 4.092

6.  Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway.

Authors:  Zhen Qi; Renrong Wang; Rongheng Liao; Song Xue; Yongyi Wang
Journal:  Front Pharmacol       Date:  2021-07-22       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.